Author

Iris Dotan 1

1 Tel Aviv Unive

A MEDITERRANEAN DIET-BASED NUTRITIONAL EDUCATION PROGRAM POSITIVELY MODIFIES THE INTESTINAL MICROENVIRONMENT OF HEALTHY INDIVIDUALS: RESULTS FROM A PROSPECTIVE INTERVENTION

Leah Reshef, Sarine Elial-Fatal, Tamar Pfeffer Gik, Barbara Raykhel, Idan Goren, Tzahi Perez, Henit Yanai, Revital Barkan, Adva Levy-Barda, Keren M Rabinowitz, Iris Dotan, Uri Gophna, Lihi Godny, Tali Sharar Fischler

ANALYSIS OF INFECTIONS OF INTEREST IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

Alessandro Armuzzi, Christina Ha, Michael Chiorean, Nervin Lawendy, Rajiv Mundayat, Leonardo Salese, John C. Woolcott, Chinyu Su, Iris Dotan

CANNABIS INDUCES SIGNIFICANT CLINICAL AND QOL IMPROVEMENT IN CHRONIC POUCHITIS

Lihi Bar-Lev Schleider, hen kayless, Timna Naftali, Iris Dotan, Efrat Broide

DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNFΑ: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY

Hadar Edelman-Klapper, Iris Dotan, Eran Zittan, Maor H. Pauker, Adi Friedenberg, Idan Goren, Ariella Bar-Gil Shitrit, Irit Avni-Biron, Jacob Ollech, Arie Segal, Lev Lichtenstein, Hagar Banai-Eran, Yelena Broytman, Yifat Snir, Eran Maoz, Baruch Ovadia, Tsachi Tsadok Perets, Henit Yanai, Rami Eliakim, Meital Gal-Tanamy, D

EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL

Laurent Peyrin-Biroulet, Iris Dotan, Alessandra Oortwijn, Brian Feagan, Toshifumi Hibi, Virginia Taliadouros, Sally Zhao, Jie Zhang, Jeremy Hsieh

HUMAN INTESTINAL EPITHELIAL CELLS INTERNALIZE LUMINAL FUNGI VIA LC3-ASSOCIATED PHAGOCYTOSIS

Sarit Cohen-Kedar, Danielle Keizer, Suzana Schwartz, Efrat Shaham Barda, Keren Masha Rabinowitz, kawsar kaboub, Eran Sadot, Ian White, Nir Wasserberg, Meirav Wolff-Bar, Adva Levi-Barda, Iris Dotan

MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES (IBD)

Hanan Abu-Taha, Elena Brook, Ian White, Nir Wasserberg, Shay Ben Shachar, Yekaterina Sorokin, David Navarro, Adva Levy-Barda, Keren M Rabinowitz, Iris Dotan

PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE

Leah Reshef, Idan Goren, Jacob Silverman, Tali Sharar Fischler, Nir Wasserberg, Maor H. Pauker, Iris Dotan, Ian White, Henit Yanai

RATE OF INAPPROPRIATE PROTON PUMP INHIBITORS PRESCRIPTION AT DISCHARGE FROM INTERNAL MEDICINE DEPARTMENTS ACCORDING TO A DEVELOPED ALGORITHM

Bronya Calivarysky, Orly Sneh-Arbib, Zohar Levi, Yaara Leibibivichi Weisman, Iris Dotan

RISK FACTORS AND EFFICACY OF BIOLOGIC THERAPY FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS AMONG PATIENTS WITH ULCERATIVE COLITIS: LONG-TERM DATA FROM A PROSPECTIVE COHORT

Ian White, Jacob Ollech, Keren M Rabinowitz, Noam Peleg, Irit Avni-Biron, Idan Goren, Lena Broitman, Yifat Snir, Hagar Banai, Henit Yanai, Nir Wasserberg, Iris Dotan

Item 1 - 10 / 12
1
2